Hepatic Artery

• 

  Subject Areas on Research

  • A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver. 
  • A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. 
  • A segmental approach to computerized tomographic portography for hepatic resection. 
  • ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective. 
  • Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. 
  • Biliary secretion of extracorporeal porcine livers with single and dual vessel perfusion. 
  • CT and MR imaging evaluation of living liver donors. 
  • CT during arterial portography: diagnostic pitfalls. 
  • Can combining triple-arterial phase acquisition with fluoroscopic triggering provide both optimal early and late hepatic arterial phase images during gadoxetic acid-enhanced MRI? 
  • Coil embolization of segmental arterial mediolysis of the hepatic artery. 
  • Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress. 
  • Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases. 
  • Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. 
  • Contralateral inflow occlusion to optimize graft volume and to reduce blood loss during parenchymal dissection in living-related liver transplantation. 
  • Contrast-enhanced hepatic magnetic resonance angiography at 3 T: does parallel imaging improve image quality? 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Curing a consumption coagulopathy with transcatheter embolization of a visceral artery aneurysm. 
  • Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. 
  • Doppler sonography of the portal vein and hepatic artery: measurement of a prandial effect in healthy subjects. 
  • Dual-Energy Multidetector-Row Computed Tomography of the Hepatic Arterial System: Optimization of Energy and Material-Specific Reconstruction Techniques. 
  • Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection. 
  • Effect of hepatic artery flow on bile secretory function after cold ischemia. 
  • Emergencies after liver transplantation. 
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. 
  • Glucagon-induced vasospasm of hepatic artery branches during visceral angiography. 
  • Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. 
  • Hepatic Arterial Infusion Pumps: What the Radiologist Needs to Know. 
  • Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications. 
  • Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. 
  • Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). 
  • Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance? 
  • Hepatic arterial resistive indices: correlation with the severity of cirrhosis. 
  • Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease. 
  • Hepatic artery: variability in measurement of resistive index and systolic acceleration time in healthy volunteers. 
  • Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients. 
  • Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases. 
  • Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. 
  • Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. 
  • Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. 
  • Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. 
  • Liver transplantation. 
  • Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. 
  • Midabdominal aortic coarctation presenting with severe pre-eclampsia. 
  • Outcome of extra-anatomic vascular reconstruction in orthotopic liver transplantation. 
  • Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. 
  • Patient and tumor characteristics predictive of an elevated hepatopulmonary shunt fraction before radioembolization of hepatic tumors. 
  • Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. 
  • Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. 
  • Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. 
  • Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. 
  • Radiation dose reduction in abdominal computed tomography during the late hepatic arterial phase using a model-based iterative reconstruction algorithm: how low can we go? 
  • Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. 
  • Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver. 
  • Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. 
  • Safety and efficacy of living donor liver preservation with HTK solution. 
  • Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement. 
  • Short-lag spatial coherence imaging on matrix arrays, part II: Phantom and in vivo experiments. 
  • Solitary intercostal arterial trunk: a previously unreported anatomical variant. 
  • Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. 
  • The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. 
  • The management of variant arterial anatomy during hepatic arterial infusion pump placement. 
  • Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate? 
  • Treatment of advanced colorectal cancer. 
  • Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. 
  • Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. 
  • [Malignant melanoma: hepatic intra-arterial chemotherapy].